Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

NCT02503735 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Unable to meet enrollment goal

Conditions

Hepatitis C
Chronic Kidney Disease

Interventions

DRUG: Sofosbuvir/Ledipasvir FDC

Sponsor

Massachusetts General Hospital